3Foley RN, Parfrey PS, Harnett JD,et al. Hypoalbuminemia,cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol , 1996,7 : 728-736.
4Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation,2003, 107:2864-2869.
5Danielski M, Ikizler TA, McMonagle E, et al. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis, 2003, 42 : 286-294.
6Borawski J, Naumnik B, Pawlak K, et al. Endothelial dysfunction marker yon Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis bloodpressure and the acute phase response. Nephrol Dial Transplant, 2001,16 : 1442-1447.
7Reuben DB, Ferrucci L, Wallace R, et al. The prognostic value of serum albumin in healthy older persons with low and high serum interleukin-6 (IL-6) levels. J Am Geriatr Soc,2000, 48: 1404-1407.
8J.R. Lentino,L.M. Baddour,M. Wray,E.S. Wong,V.L. Yu. Staphylococcus aureus and Other Bacteremias in Hemodialyis Patients: Antibiotic Therapy and Surgical Removal of Access Site[J] 2000,Infection(6):355～360
9Johannsson G,Bengtsson BA,AhlmenJ.Double-blind, placebo-controlled study ofgrowth hormone treatment in elderly patientsundergoing chronic hemodialysis: anaboliceffect and functional improvement[].American Journal of Kidney Diseases.1999
10Sanka T,Shinobe M,Ando M,et al.IGF-1 as an early indicator of malnutrition in patients with end-stage disease[].Nephron.1994
